· Published by Health Canada · Official notice
| Affected products | Lot or serial number | Model or catalogue number |
|---|---|---|
| VITEK 2 System | Not applicable. | AST-N804 |
| VITEK 2 System | Not applicable. | AST-XN42 |
| VITEK 2 Compact 30 Systems | Not applicable. | Not applicable. |
| VITEK 2 Compact 60 System | Not applicable. | Not applicable. |
BioMérieux identified increased out-of-range high quality control results for the following antibiotic formulations: ceftazidime/avibactam (CZA02n), imipenem (IPM05n), imipenem/relebactam (IPR01n), meropenem/vaborbactam (MEV01n), and polymyxin B (PB02n), as well as reports of false resistance on VITEK® 2 GN-AST Cards when testing Enterobacterales/Enterobacteriaceae and P. aeruginosa.